140 related articles for article (PubMed ID: 36342848)
1. Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function.
Trory JS; Munkacsi A; Śledź KM; Vautrinot J; Goudswaard LJ; Jackson ML; Heesom KJ; Moore SF; Poole AW; Nabet B; Aggarwal VK; Hers I
Blood Adv; 2023 May; 7(9):1692-1696. PubMed ID: 36342848
[TBL] [Abstract][Full Text] [Related]
2. Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking.
Oda A; Ikeda Y; Ochs HD; Druker BJ; Ozaki K; Handa M; Ariga T; Sakiyama Y; Witte ON; Wahl MI
Blood; 2000 Mar; 95(5):1663-70. PubMed ID: 10688822
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of Btk signaling by the atypical tec family tyrosine kinases Bmx and Txk.
Tomlinson MG; Kurosaki T; Berson AE; Fujii GH; Johnston JA; Bolen JB
J Biol Chem; 1999 May; 274(19):13577-85. PubMed ID: 10224128
[TBL] [Abstract][Full Text] [Related]
4. Dual functions of Bruton's tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis.
Jongstra-Bilen J; Puig Cano A; Hasija M; Xiao H; Smith CI; Cybulsky MI
J Immunol; 2008 Jul; 181(1):288-98. PubMed ID: 18566394
[TBL] [Abstract][Full Text] [Related]
5. The protein tyrosine kinase Tec regulates mast cell function.
Schmidt U; Abramova A; Boucheron N; Eckelhart E; Schebesta A; Bilic I; Kneidinger M; Unger B; Hammer M; Sibilia M; Valent P; Ellmeier W
Eur J Immunol; 2009 Nov; 39(11):3228-38. PubMed ID: 19688741
[TBL] [Abstract][Full Text] [Related]
6. Tec regulates platelet activation by GPVI in the absence of Btk.
Atkinson BT; Ellmeier W; Watson SP
Blood; 2003 Nov; 102(10):3592-9. PubMed ID: 12842985
[TBL] [Abstract][Full Text] [Related]
7. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines.
Matsuda T; Takahashi-Tezuka M; Fukada T; Okuyama Y; Fujitani Y; Tsukada S; Mano H; Hirai H; Witte ON; Hirano T
Blood; 1995 Feb; 85(3):627-33. PubMed ID: 7530500
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec.
Tomlinson MG; Kane LP; Su J; Kadlecek TA; Mollenauer MN; Weiss A
Mol Cell Biol; 2004 Mar; 24(6):2455-66. PubMed ID: 14993283
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3-kinase and integrin signalling are involved in activation of Bruton tyrosine kinase in thrombin-stimulated platelets.
Laffargue M; Ragab-Thomas JM; Ragab A; Tuech J; Missy K; Monnereau L; Blank U; Plantavid M; Payrastre B; Raynal P; Chap H
FEBS Lett; 1999 Jan; 443(1):66-70. PubMed ID: 9928954
[TBL] [Abstract][Full Text] [Related]
10. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo.
Yang W; Malek SN; Desiderio S
J Biol Chem; 1995 Sep; 270(35):20832-40. PubMed ID: 7657668
[TBL] [Abstract][Full Text] [Related]
11. Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.
Naylor-Adamson L; Chacko AR; Booth Z; Caserta S; Jarvis J; Khan S; Hart SP; Rivero F; Allsup DJ; Arman M
Front Immunol; 2021; 12():766272. PubMed ID: 34912339
[TBL] [Abstract][Full Text] [Related]
12. Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate.
Wang Q; Vogan EM; Nocka LM; Rosen CE; Zorn JA; Harrison SC; Kuriyan J
Elife; 2015 Feb; 4():. PubMed ID: 25699547
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of inhibiting Bruton's tyrosine kinase, (BTK).
Vassilev AO; Uckun FM
Curr Pharm Des; 2004; 10(15):1757-66. PubMed ID: 15180538
[TBL] [Abstract][Full Text] [Related]
14. Essential roles for the Tec family kinases Tec and Btk in M-CSF receptor signaling pathways that regulate macrophage survival.
Melcher M; Unger B; Schmidt U; Rajantie IA; Alitalo K; Ellmeier W
J Immunol; 2008 Jun; 180(12):8048-56. PubMed ID: 18523268
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function.
Rigg RA; Aslan JE; Healy LD; Wallisch M; Thierheimer ML; Loren CP; Pang J; Hinds MT; Gruber A; McCarty OJ
Am J Physiol Cell Physiol; 2016 Mar; 310(5):C373-80. PubMed ID: 26659727
[TBL] [Abstract][Full Text] [Related]
16. The accessory factor Nef links HIV-1 to Tec/Btk kinases in an Src homology 3 domain-dependent manner.
Tarafdar S; Poe JA; Smithgall TE
J Biol Chem; 2014 May; 289(22):15718-28. PubMed ID: 24722985
[TBL] [Abstract][Full Text] [Related]
17. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia.
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 1997 Jan; 2():d27-42. PubMed ID: 9159207
[TBL] [Abstract][Full Text] [Related]
18. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Nef dimers short-circuit immune receptor signaling by activating Tec-family kinases at the host cell membrane.
Li WF; Aryal M; Shu ST; Smithgall TE
J Biol Chem; 2020 Apr; 295(15):5163-5174. PubMed ID: 32144207
[TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.
Vassilev A; Ozer Z; Navara C; Mahajan S; Uckun FM
J Biol Chem; 1999 Jan; 274(3):1646-56. PubMed ID: 9880544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
